Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Diabetes. Oct 15, 2013; 4(5): 219-225
Published online Oct 15, 2013. doi: 10.4239/wjd.v4.i5.219
Table 1 Characteristics of sample (n = 1224) by gender and serum adiponectin (in μg/mL) tertiles
nMen (n = 561)Women (n = 663)
1 4.941
2 8.50
3 15.36
AnovaP-trend1 6.121
2 10.87
3 19.67
AnovaP-trend
MeanSDMeanSDMeanSDMeanSDMeanSDMeanSD
Age (yr)122452.210.153.81158.1411.9< 0.00152.810.353.511.957.1412< 0.001
BMI (kg/m2)121328.2429.34.327.34.5 0.2331.84630.34.830.15.7 0.003
Waist circumfer. (cm)121797.311.196.810.69511.9 0.1194.312.792.111.491.212.70.024
Systolic BP (mmHg)1217120.618.8121.319.6121.820.3 0.83130.523.9126.421.7127.323.7  0.15
Diastolic BP (mmHg)121777.810.877.710.377.610.6 0.9880.811.579.710.48011.8  0.54
Complement C3 (g/L)6101.360.271.290.271.230.270.0071.440.291.370.331.240.24< 0.001
CRP3 (mg/L)11432.261.25-5.062.111.02-3.91.4240.76-3.2< 0.0012.721.15-6.332.611.21-6.182.291.08-4.00.025
Total cholest. (mg/dL)1213191.340194.83819040.3 0.4620141.7205.453204.944.3  0.54
Fast. glucose, (mg/dL)1124993999.637.89425.8 0.27101.943.99938.293.732 0.093
ApoB (mg/dL)1116107.626.7105.328.9100.446.9 0.1510626.3104.332.5106.937.5  0.72
Creatinine (mg/dL)11441.020.191.020.220.990.22 0.240.780.210.790.180.840.420.066
Fast. triglycer.3 (mg/dL)1123160.84108-227138.1100-187126.289-174< 0.001146.2108-206133.599.9-182117483.5-164< 0.001
HDL-cholest. (mg/dL)120735.68.339.59.843411.3< 0.00143.911.545.610.649.4411.7< 0.001
Apo A-I (mg/dL)1103129.725134.725.1138.925.80.004144.326.4145.729.9152.628.10.008
Lp (a)3 (mg/dL)7648.163.8-18.27.933.2-19.49.363.4-20.6 0.5212.15.3-24.513.35.7-23.612.44-29.4  0.85
Thyroid SH3 (mIU/L)5321.060.7-1.61.050.6-1.71.010.67-1.5 0.891.530.97-2.451.470.84-2.31.371.0-2.46  0.70
Current/former smok (%)121858.42047.921.145.9 290.035163.718.63.614.73.7  0.87
Prevalent diabetes2 (%)121911.812.613.1 0.9317.712.112.9  0.18
Incident CHD, n (%)106113 (8.2)11 (6.7)4 (2.5)  0.08621 (11.1)8; 416 (8.4) 0.029